Bekris Lab

Overview

The Bekris lab focuses on identifying specific biomarker signatures that tease apart the heterogeneous nature of early pre-symptomatic disease for:

1. Biomarker characterization

2. Tracking disease progression

3. Monitoring treatment effectiveness

Pictured: Infographic of the Bekris Lab's introduction to understanding Alzheimer's disease

Pictured: Biomarker Mind Map

Pictured: Bekris Lab Research Approach Diagram 

 

In the Media

2024 LTA Member for the Year Award

• Venue: Lerner Trainee Newsletter
• https://www.lerner.ccf.org/education/documents/Aug2024NewsletterFinalCompressed.pdf
• Release Date: 8/01/24
• Topic: Recognizing LTA members for their contributions to the mission and the success of their subcommittees and LTA.

 

Blood-based Biomarkers for Alzheimer’s Disease in Women

• Venue: Cleveland Clinic Neuro Pathways Podcast
• https://consultqd.clevelandclinic.org/blood-based-biomarkers-for-alzheimers-disease-in-women-podcast/
• Release Date: 11/01/23
• Topic: A research project aims to pinpoint biomarkers that could speed diagnosis

 

Changes in the Diagnostic Process of Alzheimer Disease: A New Era of Blood-Based Approaches.

• Venue: Neurology Live 
• https://www.neurologylive.com/view/changes-diagnostic-process-alzheimer-disease-new-era-blood-based-approaches
• Release Date: 12/08/23
• Topic: The diagnostic value of biofluid biomarkers of Alzheimer's Disease.